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Two monoclonal mouse antibodies against human plasma fibronectin were compared in their reactivity 
for proteolpic fragments of the antigen by enzyme immunoassay and immunoblotting. These antibodies 
were shown to react with two different structures within a short segment (about 30 kDa) located about 
one-third away from the C-terminus of the fibronectin chains. 
Fibronectin Central region structure 
1. INTRODUCTION 
Fibronectin is a large molecule composed of two 
quite similar polypeptide chains (220-250 kDa) 
which are joined at the C-terminus by interchain 
disulphide bonds. The binding properties of 
fibronectin to eukaryotic cell surfaces, bacteria, 
heparin, gelatin, fibrin and actin can be attributed 
to specific structural domains within the molecule 
[l-3]. These domains appear to be more rigid than 
the joining polypeptide sequences and possess con- 
siderable stability against proteases. Monoclonal 
antibodies which have been raised against native 
and denatured fibronectin appear in the majority 
of cases to react against these functional domains, 
suggesting that these sites are highly antigenic 
[4- 111. Such monoclonal antibodies are potential 
probes to study the importance of specific binding 
domains for the function of fibronectin in vivo. 
They may also allow a precise analysis of the align- 
ment of these domains within the molecular struc- 
ture of fibronectin. The fibronectin molecule has 
been well characterized at the N- and C-terminal 
regions, including comprehensive sequence data 
[12,13], but the large central region of each chain 
has been more difficult to analyze. Two biological 
functions have been assigned to this central region; 
chemotaxis and cell attachment [5,14,15]. 
Monoclonal antibody Immunoblotting 
Here, we localize the antigenic determinants for 
two monoclonal antibodies to the C-terminus of 
the central region, using enzyme immunoassays 
and immunoblotting techniques with well-defined 
isolated peptides of human fibronectin. 
2. MATERIALS AND METHODS 
2.1. Preparation of monoclonal antibodies 
Monoclonal antibodies resulted from a fusion of 
NSl myeloma cells with splenocytes from BALB/c 
mice which had been immunized with human 
fibronectin (Collab. Res., Waltham MA). BALB/c 
female mice, 4-6 weeks old, were injected sub- 
cutaneously with 20 ,ug antigen which was 
emulsified in complete Freund’s adjuvant for the 
first injection, and with incomplete Freund’s adju- 
vant for the second injection. The third injection 
was given intraperitoneally without adjuvant, and 
3 days later spleens were removed for cell fusion, 
which was done as in [16]. Hybridoma super- 
natants were screened on living monolayer cell 
cultures of early postnatal mouse cerebellum by in- 
direct immunofluorescence as in [ 171. Monoclonal 
antibodies from two hybridoma clones 286 and 
317, were affinity purified on fibronectin-sepha- 
rose columns and used in these studies. The im- 
munoglobulin subclass of these antibodies was 
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determined by gel diffusion using Ig subclass 
specific antibodies (anti-IgGl, IgA and IgM were 
obtained from Miles GmbH, Frankfurt; anti- 
IgG2a and IgG2b were a generous gift of Dr 
Gerisch, Martinsried). Goat anti-mouse IgG was 
kindly supplied by Dr H.P. Neubauer (Hoechst 
AG, Frankfurt). 
2.2. Purification of fibronectin and its fragments 
Purified human plasma fibronectin [ 181 was us- 
ed for all assays and for the production of specific 
peptides. Completely unfolded fibronectin was 
prepared by reduction with 0.02 M dithioerythritol 
in 8 M urea followed by alkylation. 
The large cathepsin D-derived fragments Ca-200 
and Ca-140 (see fig. 1) were prepared by mild diges- 
tion (enzyme: substrate, 1: 300; 4 h) of human 
fibronectin as in [ 181. Fragments Ca-95 and Ca-23 
were prepared from a heparin non-binding frac- 
tion of a more processed igest (fraction I in [19]) 
by chromatography on Ultrogel AcA44. The 
chymotryptic peptide Ch-125 was obtained from a 
digest [20] dialyzed against 0.05 M Tris-HCl (pH 
7.4), 1 mM EDTA by fractionation on 
heparin-Sepharose (column 2.5 x 17 cm) using 
stepwise elution with 0.05, 0.1 and 0.5 M NaCl. 
The 0.05 M eluate was passed over 
gelatin-Sepharose and the non-adsorbed fraction 
purified on Ultrogel AcA44. Fragment Ch-60 was 
prepared from the same digest as in [20]. 
Fig.1. Scheme of a single chain of fibronectin and 
localization of fragments obtained by digestion with 
cathepsin D (Ca), chymotrypsin (Ch) and plasmin (Pl). 
The localization of antigenic determinants reacting with 
monoclonal antibodies 286 (A) and 317 ( n ) is based on 
data shown in fig.3 and 4. The large white box indicates 
the position of the gelatin-binding domain which was 
useful for affinity purification of fragments Ca-70, 
Ch-60 and PI-85. Fragment F(IV) denotes a carboxy- 
terminal fragment including the interchain disulfide 
bonds [19]. Further details are in section 2. 
Fragments Pl-85 (gelatin-binding) and Pl-90 
(gelatin-non-binding) resulted from a prolonged 
plasmin digest of fragment Ca-200 
(Forschungsplasmin KABI; enzyme :substrate, 
1:20; 24 h, 37°C) and were isolated by successive 
chromatography on gelatin-Sepharose, 
heparin-Sepharose and Ultrogel AcA44 as will be 
described elsewhere. M,-Values were determined 
by SDS gel electrophoresis [21] on 5-20% 
polyacrylamide gels, using globular proteins as M, 
standards. Protein concentrations were estimated 
spectrophotometrically using A% = 12.8 [18]. 
2.3. Immunological assays 
Binding of monoclonal antibodies with 
fibronectin was determined by radioimmunoassay 
[22] and enzyme immunoassay [23]. Fibronectin 
was labelled with lz51 using the chloramine T pro- 
cedure [22], and used in a double antibody assay. 
In the enzyme immunoassay microtiter plates 
(Greiner Labortechnik, Nurtingen) were coated 
with 25-50 /cg/ml of fibronectin, and peroxidase- 
conjugated anti-mouse IgG (Miles GmbH, 
Frankfurt) was used in the second phase. 
5-Amino-2-hydroxy-benzoate 0.8 mg/ml (Ega- 
Chemie, Steinheim/Albuch) was used as the 
substrate for the peroxidase reaction [23]. The 
bound product was solubilized with 1 N NaOH 
and measured at 492 nm. 
In the inhibition assays peptide samples ranging 
from 1.6-50 nM were incubated overnight at 4°C 
with monoclonal antibodies (0.2-0.4 pg/ml) 
before application to the microtiter plates coated 
with fibronectin (25 pg/ml). 
For immunoblotting, 5-10 pg peptide prepara- 
tions were electrophoretically separated on 6- 15 % 
SDS-polyacrylamide gels, and then transferred to 
nitrocellulose paper (Bio-Rad) by Western blotting 
according to [24], at a constant 0.3 A overnight at 
4°C. After transfer nitrocellulose sheets were 
washed in water and incubated in a blocking solu- 
tion, 2.5% bovine serum albumin (Behringwerke 
AG, Marburg) in Tris-buffered saline (TBS) (pH 
7.2) for 2 h at room temperature with constant 
shaking. Sheets were subsequently incubated in 
monoclonal antibodies at 2.0pg/ml in blocking 
solution for 2 h, washed in several changes of 
TBS, and incubated in peroxidase-conjugated goat 
anti-mouse IgG (Miles) at a 1 :400 dilution in 
blocking solution for 2 h. After further washing in 
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TBS, antigen-antibody complexes were visualized 
by incubating filters in a substrate solution con- 
taining 0.5 mglml catechol {Merck, Darmstadt) 
and 0.5 mglml 1,4-phenylen~iamine (Merck) in 
0.1 M cacodylate buffer (pH 6.0) for 2-5 min (H. 
Perry, Oxford, personal communication). Filters 
were washed in TBS and stored in water before 
photography. 
3. RESULTS AND DISCUSSION 
Both monoclonal antibodies 317 and 286 were 
shown to belong to the IgGl subclass by gel diffu- 
sion. They showed an equal reactivity against 
native fibronectin in enzyme immunoassay (fig.2). 
The antibodies also showed comparable binding to 
‘251-labelled fibronectin but precipitated 960% of 
the antigen even in extreme antibody excess. Reac- 
tion with only a portion of the antigen has also 
been found with other monoclonal antibodies; for 
example, those against collagen type I [25]. Both 
reactions were totally inhibited by as little as 3 nM 
purified fibronectin (fig.3). The antibodies showed 
similar reactivity against reduced and alkylated 
fibronectin both in binding and inhibition assays 
(not shown) indicating that the antigenic deter- 
minants are in the primary amino acid sequence 
rather than the disulphide-linked tertiary structure. 
r- 
10 1 OJ 
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Fig.2. Reaction of monoclonal antibodies 286 (0) and 
317 (0) with fibronectin in enzyme immunoassay. The 
microtiter wells were coated with fibronectin (50 pg/ml) 
and bound antibody detected by reaction with 
peroxidase-conjugated anti-mouse Ig antiserum follow- 
ed by the enzymic reaction which was measured at 
492 nm. Background values obtained with normal IgG 
were subtracted. 
Fig.3. Inhibition of binding of monoclonal antibodies 
286 and 3 17 to fibronectin in enzyme immunoassay by 
fibronectin fragments. Inhibitors of the reaction were 
fibronectin (0) and fragments Ca-140 (A), Ca-95 (0), 
Ca-70 (A), Ca-23 (o), Ch-125 (v), Ch-60 (v), PI-90 ( n ) 
and Pl-85 ( KI). These fragments are described in fig. 1. 
Microtiter plates were coated with fibronectin 
(25 pg/ml). Rest&s are expressed as reduction in binding 
of antibody compared to a non-inhibited control. 
This has also been demonstrated with other 
monoclonal antibodies [7]. 
The proteolytic fragments which were tested for 
antibody binding are presented in diagrammatic 
form in fig. 1, showing their positions in the intact 
fibronectin molecule. Antibodies 317 and 286 
reacted only with fragments arising from the large 
central region, and not with N- or C-terminal 
fragments. The large central cathepsin D frag- 
ment, Ca-140, released in early digestion, and a 
similar chymotryptic fragment, Ch-125, were 
equivalent o the intact fibronectin molecule in in- 
hibition assays with antibody 286 and only 5-fold 
less active with antibody 317 (fig.3). Both 
fragments also reacted very strongly in an im- 
munoblot reaction (fig.4). Gelatin-binding 
fragments, Ch-60 and Ca-70, which are located at 
the N-terminal site of fibronectin, showed weak in- 
hibiting activity (fig.3), and when these peptides 
were transferred to nitrocellulose it was evident 
that reactivity was confined to small amounts of 
contaminating higher-Mr fragments in these 
preparations (fig.4). Likewise, the C-terminal 
F(W) fragment 1191 did not contain antigenic 
determinants for these antibodies (not shown). 
The different specificities of the two antibodies 
were only revealed with smaller fragments released 
upon further digestion of the central region. The 
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Fig.4. immunobfot reaction of monoclonal antibodies with cathepsin D fragments of fibronectin. The various 
fragments (Ca-15 to Ca-140, see fig. 1) were electrophoretically separated in SDS-polyacrylamide gels and visualised 
either by staining with Coomassie blue (lanes 1) or after transfer to nitrocelluiose and reaction with monoclonal 
antibodies 317 (lanes 2) or 286 (lanes 3) by peroxidase reaction. The numbers on both sides indicate the kDa-values of 
major peptides. 
Ca-95 fragment which does not bind to 
heparin-Sepharose did not react with either an- 
tibody in inhibition assays or by immunoblotting 
(fig.3,4). A smaller Ca-18 fragment which lies next 
to the gelatin-binding domain [ZO] was also 
negative by immunoblot with 286 and 317 an- 
tibodies. However, a Ca-23 peptide generated at an 
intermediate stage of cathepsin D digestion of in- 
tact fibronectin retained activity with antibody 317 
but not 286. When this fragment was purified, a 
very strong reaction was observed in an im- 
munoblot reaction with antibody 317 (fig.4), and 
distinct activity was demonstrated in inhibition 
assays, although not as strong as the Ca-140 or 
Ch-125 fragments (fig.3). Complete digestion of 
Ca-140 with cathepsin D revealed smaller peptides 
which retained binding activity for antibody 317, 
the smallest being fragment Ca-15 (15 kDa) (fig.4). 
The localization of these Ca-23 and Ca-15 peptides 
to the C-terminus of the central region was con- 
firmed after plasmin digestion of the large Ca-200 
fragment. Three peptides were generated, a Pl-30 
N-terminal fragment, a P l-85 gelatin-binding frag- 
ment, and a Pl-90 non-gelatin-binding fragment 
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(fig.1). Reactivity of both 286 and 317 antibodies 
was restricted to the Pl-90 piece (fig.3), indicating 
that both determinants had to be placed to the C- 
terminus of fragment Ca-140. Loss of the 286 an- 
tigenic determinant in the later cathepsin D digests 
could indicate its position at the site of cleavage 
between the Ca-95 and Ca-23 fragments, or on a 
missing fragment (about 7 kDa) which could be 
positioned between these two. Further cathepsin D 
digestion of the Pl-90 and Ch-125 pieces also 
generated fragments with electrophoretic mobility 
similar to Ca-15 and which also reacted only with 
antibody 317. This pattern indicates that the 3 17 
determinant lies at the very end of the central 
region, with the 286 determinant presumably close 
to it at its N-terminus (fig-l). 
We have demonstrated here how monoclonal 
antibodies can be used in conjunction with well- 
defined proteoiytic fragments of fibronectin to ac- 
curately determine the position of antigenic deter- 
minants. The 286 and 317 determinants lie within 
a region which contains the chemotactic and cell- 
binding activities of fibronectin. When fibronectin 
fragments are assayed for these activities it is clear 
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that the Ca-140 fragment is highly active in pro- 
moting chemotaxis and cell attachment, while the 
Ca-95 fragment has no activity ([26], Aumailley, 
unpublished). The chemotactic site has been 
localized to the Ca-23 fragment [26]. In [5], cell at- 
tachment was inhibited by a monoclonal antibody 
which reacts with a 15 kDa peptide from the cen- 
tral region of fibronectin. This fragment cor- 
responds to the 317 reacting Ca-15 fragment here. 
A synthetic peptide, consisting of only 30 amino 
acid residues, is sufficient to promote cell attach- 
ment [27]. It is not yet clear whether the same 
structural domain of fibronectin is responsible for 
both chemotactic and cell-binding activities. Since 
both antibodies react with completely reduced 
fibronectin the elucidation of the structure of an- 
tigenic determinants is feasible, and should allow a 
precise correlation between antigenic and 
biological activities. 
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